Back to search

Reishi, Lingzhi · 2023 · Journal Article

High relevance

Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling.

Ganoderma lucidum

OncologyImmune supportMetabolic healthLiver support
SpeciesReishi, Lingzhi
JournalPhytomedicine: international journal of phytotherapy and phytopharmacology
Year2023

Metadata-grounded summary

Article summary

Metadata-grounded summary: This journal article indexes research on Ganoderma lucidum in Phytomedicine: international journal of phytotherapy and phytopharmacology in 2023. MycoData maps the paper to oncology, immune support, metabolic health, liver support based on its title, species context, article metadata, and study classification.

Citation

Chen C, Chen J, Wang Y, Fang L, Guo C, Sang T, et al. (2023). Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling. Phytomedicine: international journal of phytotherapy and phytopharmacology https://doi.org/10.1016/j.phymed.2022.154626 PMID: 36603342

Open citation